Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.24 USD | -0.13% | -0.91% | -17.77% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.76% | 3.13B | |
+5.37% | 32.61B | |
+22.28% | 7.98B | |
+25.15% | 3.99B | |
-20.09% | 1.38B | |
-30.40% | 1.2B | |
+7.40% | 959M | |
-34.66% | 915M | |
-26.60% | 819M | |
-18.08% | 700M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Canaccord Genuity Cuts Price Target on Evolent Health to $45 From $47, Maintains Buy Rating